The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of M6620 and irinotecan in TP53 mutant gastric and gastroesophageal junction (GEJ) adenocarcinoma patients (pts) [NCT03641313].
 
Satya Das
Honoraria - Targeted Oncology
 
Jennifer Whisenant
Research Funding - EMD Serono (Inst)
Patents, Royalties, Other Intellectual Property - I am listed as an inventor on a patent licensed to Anasys Instruments.
 
Austin Doyle
No Relationships to Disclose
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Jordan Berlin
Honoraria - genentech; Nestle health science
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; BeiGene; Celgene; Cornerstone Pharmaceuticals; Eisai; EMD Serono; ERYTECH Pharma; Exelixis; Five Prime Therapeutics; Genentech/Roche; Gritstone Bio; Karyopharm Therapeutics; Symphogen
Research Funding - Bayer (Inst); BeiGene (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Loxo (Inst); Pharmacyclics (Inst); symphogen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; EMD Serono; Genentech/Roche; Nestle health science
Other Relationship - AstraZeneca